Galderma Group AG
GALD
Rank in Stocks
#457
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Share Price
$224.81
Market Cap
$52.42B
Change (1 day)
6.31%
Change (1 year)
31.28%
Country
CH
Trade Galderma Group AG (GALD)
Category
Healthcare
Dividend yield history for Galderma Group AG (GALD)
Galderma Group AG (stock symbol: GALD) dividend yield (TTM) as of 2024-12-31: 0.00%
Average dividend yield, last 5 years : 0.02%
Average dividend yield, last 5 years : 0.02%
Dividend yield history for Galderma Group AG (GALD) from 2021 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 0.19% | 137.50% |
| 2025 | 0.08% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.91% |
IN
|
|
| 0.43% |
CN
|
